The necrobiosis lipoidica diabeticorum market is projected to grow from USD 5.1 billion in 2025 to USD 9.1 billion by 2035, at a CAGR of 6.0%. Treatment will dominate with a 63.1% market share, while hospitals will lead the application segment with a 71.4% share.